Home
/
ALIREPOTINIB
ALIREPOTINIB
Repotrectinib
Quantity
-
DetailGeneric (INN)RepotrectinibStrength40mgPackaging60 capsules/bottleIndicationTargeted treatment for ROS1-positive lung cancer and NTRK-fusion cancers. (See package insert.)Registration No.09 L 1388/25Package InsertDocuments
-
Customer ReviewsNo comments
USD